159 related articles for article (PubMed ID: 37101699)
1. A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation.
Sato M; Goto M; Yamanouchi K; Sakurai H
Front Physiol; 2023; 14():1094359. PubMed ID: 37101699
[TBL] [Abstract][Full Text] [Related]
2. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
6. Targeting fibrosis in Duchenne muscular dystrophy.
Zhou L; Lu H
J Neuropathol Exp Neurol; 2010 Aug; 69(8):771-6. PubMed ID: 20613637
[TBL] [Abstract][Full Text] [Related]
7. Dental pulp stem cells can improve muscle dysfunction in animal models of Duchenne muscular dystrophy.
Nitahara-Kasahara Y; Kuraoka M; Guillermo PH; Hayashita-Kinoh H; Maruoka Y; Nakamura-Takahasi A; Kimura K; Takeda S; Okada T
Stem Cell Res Ther; 2021 Jan; 12(1):78. PubMed ID: 33494794
[TBL] [Abstract][Full Text] [Related]
8. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
Bozycki L; Łukasiewicz K; Matryba P; Pikula S
Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
10. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
[TBL] [Abstract][Full Text] [Related]
11. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
[TBL] [Abstract][Full Text] [Related]
12. Stem cell-based therapies for Duchenne muscular dystrophy.
Sun C; Serra C; Lee G; Wagner KR
Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
[TBL] [Abstract][Full Text] [Related]
13. Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis.
Taglietti V; Kefi K; Bronisz-Budzyńska I; Mirciloglu B; Rodrigues M; Cardone N; Coulpier F; Periou B; Gentil C; Goddard M; Authier FJ; Pietri-Rouxel F; Malfatti E; Lafuste P; Tiret L; Relaix F
Acta Neuropathol Commun; 2022 Apr; 10(1):60. PubMed ID: 35468843
[TBL] [Abstract][Full Text] [Related]
14. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
16. Pig models for Duchenne muscular dystrophy - from disease mechanisms to validation of new diagnostic and therapeutic concepts.
Stirm M; Fonteyne LM; Shashikadze B; Stöckl JB; Kurome M; Keßler B; Zakhartchenko V; Kemter E; Blum H; Arnold GJ; Matiasek K; Wanke R; Wurst W; Nagashima H; Knieling F; Walter MC; Kupatt C; Fröhlich T; Klymiuk N; Blutke A; Wolf E
Neuromuscul Disord; 2022 Jul; 32(7):543-556. PubMed ID: 35659494
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin-deficient large animal models: translational research and exon skipping.
Yu X; Bao B; Echigoya Y; Yokota T
Am J Transl Res; 2015; 7(8):1314-31. PubMed ID: 26396664
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
19. In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death.
Kihara Y; Tanaka Y; Ikeda M; Homma J; Takagi R; Ishigaki K; Yamanouchi K; Honda H; Nagata S; Yamato M
Regen Ther; 2022 Dec; 21():486-493. PubMed ID: 36313392
[TBL] [Abstract][Full Text] [Related]
20. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.
Sun C; Choi IY; Rovira Gonzalez YI; Andersen P; Talbot CC; Iyer SR; Lovering RM; Wagner KR; Lee G
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32343677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
